Webhealth Logo

A Network Connecting Health Care Professionals
Connecting Millions Of MDs, Hospitals and Clinics

sign up

log in

Webhealth Logo
  • Home
  • HealthCare Pros
    • US Medical Doctor Directory
    • US Nurse Directory
    • Sign Up or Log In
  • HealthCare Directory
    • US Hospital Directory
    • US Clinic Directory
    • US Pharmacy Directory
    • US Lab Directory
  • Clinical Trials
    • Search by Name and Date
    • Clinical Trials By Letter
  • Videos
  • Solutions
  • About Us
  • Log-In
  • Sign-Up
Search for Clinical Trial Results

Search and View Clinical Trials by Topic

Adenomyoepithelioma - 25 Studies Found

Status Study
Not yet recruiting Study Name: Study to Evaluate Efficacy and Safety of Sunitinib in Patients With Renal Cell Carcinoma Who Have Progressed to First-line Immunotherapy Treatment
Condition: Clear Cell Renal Carcinoma
Date: 2017-02-23
Interventions: Drug: Sunitinib Sunitinib 50 mg/d
Recruiting Study Name: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium
Condition: Ovarian Clear Cell Carcinoma Endometrial
Date: 2016-07-22
Interventions: Drug: Nintedanib Nintedanib (B
Recruiting Study Name: MEDI4736 Combinations in Metastatic Renal Cell Carcinoma
Condition: Renal Clear Cell Carcinoma Renal Papillary Cell Carcinoma
Date: 2016-02-22
Interventions: Drug: Savolitinib Other Names:
Active, not recruiting Study Name: Cabozantinib-S-Malate in Treating Patients With Recurrent or Progressive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Condition: Fallopian Tube Clear Cell Adenocarcinoma Ovarian Clear Cell Adenocarcinoma
Date: 2014-12-09
Interventions: Drug: Cabozantinib S-malate Gi
Active, not recruiting Study Name: Dasatinib in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, Endometrial or Peritoneal Cancer
Condition: Endometrial Clear Cell Adenocarcinoma Estrogen Receptor Negative
Date: 2014-02-07
Interventions: Drug: Dasatinib Given PO
Recruiting Study Name: A Study of ENMD-2076 in Ovarian Clear Cell Cancers
Condition: Ovarian Clear Cell Carcinoma
Date: 2013-07-11
Interventions: Drug: ENMD-2076
Recruiting Study Name: Sunitinib® in Patients With Recurrent Ovarian Clear Cell Carcinoma
Condition: Ovarian Cancer Adverse Effects
Date: 2013-03-19
Interventions: Drug: Sunitinib 37.5mg everyday from D1-D28 Other Na
Withdrawn Study Name: Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)
Condition: Endometrioid Carcinoma Clear Cell Carcinoma
Date: 2012-11-18
Recruiting Study Name: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
Condition: Ewing Sarcoma Gastrointestinal Tumor Germ Cell Tumor
Date: 2012-06-19
Interventions: Drug: alemtuzumab Patients rec
Completed Study Name: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
Condition: Ovarian Clear Cell Cystadenocarcinoma Stage III Ovarian Cancer
Date: 2010-09-04
Interventions: Drug: Carboplatin Given IV
Page 1 of 3
Next >>>

About

  • About Us
  • Terms of Use
  • Privacy Policy
  • Opt-Out & Information Removal
  • Contact Us
  • Advertising Privacy Policy

  • Webhealth Logo

Network Sites

  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • cancerHealthCenter
  • MentalHealthHelpCenter
  • OrthopedicsHealth
  • skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • painHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter

Partner Offers

  • All Offer
  • US
  • Canadian
  • Latin America
  • European
  • Asia Pacific
  • Other

Additional

  • Advertise With Us
  • Our Brands

WebHealth Network

WebHealth Network is the leading aggregator of health, fitness, and wellness news and information from across the Web. We provide our readers with the deepest access to health information from the most trusted health publishers.

We aim to be a one stop for all the info you need to stay healthy.

Our sources include hundreds of blogs, health sites, government sites, pharmaceutical manufacturers and much more. All the information provided is publicly available and is updated daily.

Not a Substitute for Medical Advise

WebHealth Network is designed for educational purposes only. The information provided is not a substitute for professional medical advise, diagnoses, or treatment. If you are experiencing problems with your health, it is recommended that you consult a medical professional, doctor, or other health care professional. Do not delay or avoid seekeing medical advise from a professional because of any information listed on WebHealth Network. The use of the information provided on the site is at your own risk.

Ongoing medical research may change or impact the information listed on WebHealth Network. No assurances are provided that the information listed will include the most updated developments.

If you are you are experiencing a medical emergency, please call your health care professional immediately.